$FDMT 4D Molecular Therapeutics Inc. Insider Trading
Get free email notifications about insider trading in 4D Molecular Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in 4D Molecular Therapeutics Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in 4D Molecular Therapeutics Inc. for free.
CIK Number: 0001650648
IRS Number: 473506994
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: FDMT
Company Address: 5858 HORTON STREET #455 EMERYVILLE 94608
Phone number: (510) 505-2680
Former name: 4D Molecular Therapeutics Inc, date of change: 2015-08-11
4D Molecular Therapeutics Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 19 2021 | FDMT | 4D Molecular Thera ... | MILLIGAN JOHN F | Director | Option Exercise | A | 26.89 | 11,250 | 302,513 | 11,250 | |
May 19 2021 | FDMT | 4D Molecular Thera ... | MILLIGAN JOHN F | Director | Option Exercise | A | 26.89 | 22,500 | 605,025 | 22,500 | |
May 19 2021 | FDMT | 4D Molecular Thera ... | Miller-Rich Nancy | Director | Option Exercise | A | 26.89 | 22,500 | 605,025 | 22,500 | |
May 19 2021 | FDMT | 4D Molecular Thera ... | MILLIGAN JOHN F | Director | Option Exercise | A | 26.89 | 11,250 | 302,513 | 11,250 | |
May 19 2021 | FDMT | 4D Molecular Thera ... | MILLIGAN JOHN F | Director | Option Exercise | A | 26.89 | 22,500 | 605,025 | 22,500 | |
May 19 2021 | FDMT | 4D Molecular Thera ... | Miller-Rich Nancy | Director | Option Exercise | A | 26.89 | 22,500 | 605,025 | 22,500 | |
May 19 2021 | FDMT | 4D Molecular Thera ... | Tomasello Shawn | Director | Option Exercise | A | 26.89 | 22,500 | 605,025 | 22,500 | |
Apr 14 2021 | FDMT | 4D Molecular Thera ... | Moretti August J | Chief Financial Off ... | Option Exercise | M | 9.41 | 1,000 | 9,410 | 223,060 | |
Apr 14 2021 | FDMT | 4D Molecular Thera ... | Moretti August J | Chief Financial Off ... | Buy | M | 9.41 | 1,000 | 9,410 | 2,000 | 1,000 to 2 K (+100.00 %) |
Mar 10 2021 | FDMT | 4D Molecular Thera ... | Kamal Fariborz | See Remarks | Option Exercise | A | 41.66 | 60,000 | 2,499,600 | 60,000 | |
Mar 10 2021 | FDMT | 4D Molecular Thera ... | Kirn David | See Remarks | Option Exercise | A | 41.66 | 150,000 | 6,249,000 | 150,000 | |
Dec 17 2020 | FDMT | 4D Molecular Thera ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 833,333 | 0 | 0 | |
Dec 17 2020 | FDMT | 4D Molecular Thera ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 2,004,581 | 0 | 0 | |
Dec 17 2020 | FDMT | 4D Molecular Thera ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 23.00 | 1,100,000 | 25,300,000 | 3,937,914 | 2.8 M to 3.9 M (+38.76 %) |
Dec 17 2020 | FDMT | 4D Molecular Thera ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 833,333 | 0 | 2,837,914 | 2 M to 2.8 M (+41.57 %) |
View all 4D Molecular Therapeutics Inc. insider transactions.